Br?nder, Marie-Christine	89682
Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics
Ranibizumab in retinopathy of prematurity - one-year follow-up of ophthalmic outcomes and two-year follow-up of neurodevelopmental outcomes from the CARE-ROP study
Real-life medium term follow-up data for intravitreal dexamethasone implant in retinal vein occlusion
Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity
[Use of artificial intelligence in screening for diabetic retinopathy at aÂ tertiary diabetes center].
Anti-drug antibodies to brolucizumab and ranibizumab in serum and vitreous of patients with ocular disease.
Assessment of Retinopathy of Prematurity Regression and Reactivation Using an Artificial Intelligence-Based Vascular Severity Score.